Skip to content

   Pharma Publications

Neuropsychopharmacology
  • There is still so much work to be done: a mother’s perspective
    Published on 2025-09-25
    12 months ago
  • Fueling the future: brain bioenergetics as a driver of neurodevelopment and mental health trajectories
    Published on 2025-09-25
    12 months ago
  • Clozapine induces perineuronal net remodeling in a developmental mouse model exhibiting schizophrenia-relevant phenotypes
    Published on 2025-09-25
    12 months ago
  • Change in brain molecular landscapes following electrical stimulation of the nucleus accumbens
    Published on 2025-09-25
    12 months ago
  • Acute effects of MDMA, MDA, lysine-MDMA, and lysine-MDA in a randomized, double-blind, placebo-controlled, crossover trial in healthy participants
    Published on 2025-09-25
    12 months ago
  • Cannabinoid CB1 receptor and mu-opioid receptor interaction: new insights from conditional knockout mice
    Published on 2025-09-25
    12 months ago
  • Concerted elevations of cortical and striatal glutamate and GABA in antipsychotic-free individuals at clinical high-risk for psychosis
    Published on 2025-09-25
    12 months ago
« Previous 1 … 45 46 47 48 49 … 143 Next »
Journal of Psychopharmacology
  • Towards precision dosing in psychiatry: Population pharmacokinetics meta-modelling of clozapine and lithium
    Published on 2024-09-30
    2 years ago
  • Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat
    Published on 2024-09-28
    2 years ago
  • Aspirin may be more suitable for patients with major depression: Evidence from two-sample Mendelian randomization analysis
    Published on 2024-09-25
    2 years ago
  • Optimizing the individual dosing of paroxetine in major depressive disorder with therapeutic drug monitoring
    Published on 2024-09-25
    2 years ago
  • Serotonin release by parachloroamphetamine in rats with high and low sociability: High prefrontal release capacity in sociable females
    Published on 2024-09-25
    2 years ago
  • Clinical effects of CYP2D6 phenoconversion in patients with psychosis
    Published on 2024-09-23
    2 years ago
  • Influence of panic disorder and paroxetine on brain functional hubs in drug-free patients
    Published on 2024-09-23
    2 years ago
« Previous 1 … 45 46 47 48 49 … 154 Next »
European Neuropsychopharmacology
  • Shared vulnerability and sex-dependent polygenic burden in psychotic disorders
    Published on 2024-06-28
    2 years ago
  • Gray matter volumetric correlates of the polygenic risk of depression: A study of the Human Connectome Project data
    Published on 2024-06-27
    2 years ago
  • Open science in biomedicine: Overcoming barriers in omics studies
    Published on 2024-06-27
    2 years ago
  • Ketamine treatment for anhedonia in unipolar and bipolar depression: a systematic review
    Published on 2024-06-25
    2 years ago
  • Intranasal esketamine and manic symptoms: A disproportionality analysis in EudraVigilance
    Published on 2024-06-25
    2 years ago
  • Addressing concerns of sample overlap in meta-analysis: A response to the letter by Ben Haouala and Amamou, 2024
    Published on 2024-06-25
    2 years ago
  • Network meta-analysis (NMA) of dextromethorphan-bupropion (AXS-05) efficacy and safety in major depressive disorder
    Published on 2024-06-25
    2 years ago
« Previous 1 … 45 46 47 48 49 … 170 Next »

   Pharma Pub